BMJ 2000;320:337-341 ( 5 February )

Papers

Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry

Bernadette Modell, professor of community genetics, ^b Rodney Harris, professor of medical genetics, ^a Beverley Lane, research nurse for Confidential Enquiry into Counselling for Genetic Disorders, ^a Maren Khan, research midwife, ^b Matthew Darlison, research fellow, ^c Mary Petrou, clinical molecular geneticist, ^d John Old, clinical molecular geneticist, ^f Mark Layton, senior lecturer, ^e Lysandros Varnavides, clinical molecular geneticist. ^e

^a St Mary's Hospital, Manchester M13 0JH, ^b Royal Free and University College London Medical School, Department of Primary Care and Population Sciences, Whittington Hospital, London N19 5NF, ^c Royal Free and University College London Medical School, Centre for Health Informatics and Multiprofessional Education, Whittington Hospital, ^d Royal Free and University College London Medical School, Department of Obstetrics and Gynaecology, London WC1E 6HX, ^e King's College Hospital Medical School, Department of Haematological Medicine, King's College Hospital, London SE5 9RS, ^f Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DU

Correspondence to: B Modell b.modell{at}ucl.ac.uk

Objective: National audit of informed choice in antenatal screening for thalassaemia.
Design: Audit from the UK Confidential Enquiry into Counselling for Genetic Disorders.
Setting: Thalassaemia module of the UK Confidential Enquiry into Counselling for Genetic Disorders.
Subjects: 138 of 156 couples who had had a pregnancy affected by a major  thalassaemia from 1990 to 1994.
Main outcome measures: How and when genetic risk was identified for each couple, and whether and when prenatal diagnosis was offered.
Results: Risk was detected by screening before or during the first pregnancy in 49% (68/138) of couples and by diagnosis of an affected child in 28% (38/138) of couples. Prenatal diagnosis was offered in 69% (274/400) of pregnancies, ranging from 94% (122/130) for British Cypriots to 54% (80/149) for British Pakistanis and from 90% in the south east of England to 39% in the West Midlands. Uptake of prenatal diagnosis was 80% (216/274), ranging from 98% (117/120) among British Cypriots in either the first or second trimester to 73% (35/48) among British Pakistanis in the first trimester and 39% (11/28) in the second trimester. A demonstrable service failure occurred in 28% (110/400) of pregnancies, including 110 of 126 where prenatal diagnosis was not offered and 48 of 93 that ended with an affected liveborn infant.
Conclusion: Although antenatal screening and counselling for haemoglobin disorders are standard practices in the United Kingdom, they are delivered inadequately and inequitably. An explicit national policy is needed, aiming to make prenatal diagnosis in the first trimester available to all couples and including ongoing national audit.

---

© BMJ 2000
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Confidential inquiries should be funded in clinical genetics

Kirsty Challen, Hilary J Harris, Rodney Harris, Bernadette Modell, Bruce Ponder, and Charles Rodeck
BMJ 2001 322: 1061. [Extract] [Full Text]

Haemoglobinopathy screening can be carried out in general practice

Jane Logan
BMJ 2000 320: 1542. [Extract] [Full Text]

UK screening programme for haemoglobin disorders fails to reach many couples
BMJ 2000 320: 0. [Full Text]

This article has been cited by other articles:

• Qureshi, N., Armstrong, S., Modell, B. (2006). GPs' opinions of their role in prenatal genetic services: a cross-sectional survey. Fam Pract 23: 106-110 [Abstract] [Full text]  
• Dormandy, E., Michie, S., Hooper, R., Marteau, T. M (2005). Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices?. Int J Epidemiol 34: 346-352 [Abstract] [Full text]  
• Aalfs, C. M, Smets, E. M., de Haes, H. C., Leschot, N. J (2003). Referral for genetic counselling during pregnancy: limited alertness and awareness about genetic risk factors among GPs. Fam Pract 20: 135-141 [Abstract] [Full text]  
• Henneman, L, Bramsen, I, van der Ploeg, H M, Ader, H J, van der Horst, H E, Gille, J J P, ten Kate, L P (2001). Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J. Med. Genet. 38: 695-703 [Full text]  
• Gillott, J. (2001). Screening for disability: a eugenic pursuit?. J. Med. Ethics 27: 21ii-23ii [Abstract] [Full text]  
• Challen, K., Harris, H. J, Harris, R., Modell, B., Ponder, B., Rodeck, C. (2001). Confidential inquiries should be funded in clinical genetics. BMJ 322: 1061-1061 [Full text]  
• Logan, J. (2000). Haemoglobinopathy screening can be carried out in general practice. BMJ 320: 1542-1542 [Full text]  
• Streetly, A. (2000). A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. BMJ 320: 1353-1354 [Full text]  

Rapid Responses:

Read all Rapid Responses

What does it mean for clients to have informed choice?

W Eboh, et al.
bmj.com, 11 Feb 2000 [Full text]

Haemoglobinopathy Screening in General Practice

Jane Logan
bmj.com, 22 Feb 2000 [Full text]

Reply to Eboh and van den Akker

Bernadette Modell
bmj.com, 3 Mar 2000 [Full text]

Online poll

Find out more here>> and here>>